Skip to main content
OpenTrials
Completed

NCT Number: NCT01099696

Study to Evaluate a Probiotic in Healthy Subjects With a History of Abdominal Discomfort and Bloating

This is a multicenter, double-blind, randomized, placebo-controlled, 6-week study of a probiotic for abdominal discomfort and bloating in healthy subjects.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Research Site, Chicago, Illinois, United States

Loading trial locations.

About this study

This is a multicenter, double-blind, randomized, placebo-controlled, parallel-group, 6-week study of a probiotic for abdominal discomfort and bloating in healthy subjects.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • healthy men and non-pregnant, non-lactating women aged 18 to 75 years of age;
  • Body Mass Index (BMI) < or = 40;
  • if female, postmenopausal or using adequate contraception
  • if over 50 years of age, have had a colonoscopy performed in the previous 5 years with findings that are normal for this population
  • be willing to refrain from taking dietary supplements or other foods that contain fermented live bacteria during the study and be willing to refrain from taking any medications or preparations that treat lower digestive upsets
  • have experienced abdominal discomfort and bloating at least twice a week, on average, over the last 3 months.

Exclusion criteria

  • have been under a physician's care for functional bowel disorders within the past year or have taken prescription medication for functional bowel disorders within the past year;
  • have alarm symptoms suggestive of an underlying disease;
  • have prior GI surgery (appendectomy and hernia repair are not excluded and cholecystectomy at least 3 years ago is not excluded);
  • have a significant acute or chronic coexisting illness or condition;
  • have used systemic steroidal agents within the last 30 days;
  • have used oral or systemic antibiotics within the last 30 days;
  • have used probiotics at least 3 times a week within the last 30 days;

Treatment and study plan

B. infantis 35624

Dietary Supplement

B. infantis 35624 in white capsules

Placebo

Dietary Supplement

white placebo capsules

Primary outcomes

  1. The change in abdominal discomfort and bloating

    Time frame: 4 weeks

Sponsors and collaborators

Lead sponsor

Procter and Gamble

Industry

Registry information

Official study title

A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Evaluate the Benefit of a Probiotic (Bifidobacterium Infantis 35624) in Healthy Subjects With a History of Abdominal Discomfort and Bloating

Important dates

Study start
2010
Primary completion
2010
Study completion
2010
First posted
Apr 7, 2010
Registry last updated
Dec 20, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.